Perspectives in diabetes - Molecular mechanisms of insulin resistance that impact cardiovascular biology

被引:162
作者
Wang, CCL
Goalstone, ML
Draznin, B
机构
[1] Vet Affairs Med Ctr, Res Serv, Denver, CO USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80202 USA
关键词
D O I
10.2337/diabetes.53.11.2735
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin resistance is concomitant with type 2 diabetes, obesity, hypertension, and other features of the metabolic syndrome. Because insulin resistance is associated with cardiovascular disease, both scientists and physicians have taken great interest in this disorder. Insulin resistance is associated with compensatory hyperinsulinemia, but individual contributions of either of these two conditions remain incompletely understood and a subject of intense investigation. One possibility is that in an attempt to overcome the inhibition within the metabolic insulin-signaling pathway, hyperinsulinemia may continue to stimulate the mitogenic insulin-signaling pathway, thus exerting its detrimental influence. Here we discuss some of the effects of insulin resistance and mechanisms of potentially detrimental influence of hyperinsulinemia in the presence of metabolic insulin resistance.
引用
收藏
页码:2735 / 2740
页数:6
相关论文
共 55 条
[1]  
Blankard W. G., 1997, P205
[2]   INSULIN-LIKE GROWTH-FACTOR-I AND PLATELET-DERIVED GROWTH FACTOR-BB INDUCE DIRECTED MIGRATION OF HUMAN ARTERIAL SMOOTH-MUSCLE CELLS VIA SIGNALING PATHWAYS THAT ARE DISTINCT FROM THOSE OF PROLIFERATION [J].
BORNFELDT, KE ;
RAINES, EW ;
NAKANO, T ;
GRAVES, LM ;
KREBS, EG ;
ROSS, R .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) :1266-1274
[3]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[4]   Potentiation of Rho-A-mediated lysophosphatidic acid activity by hyperinsulinemia [J].
Chappell, J ;
Golovchenko, I ;
Wall, K ;
Stjernholm, R ;
Leitner, JW ;
Goalstone, M ;
Draznin, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (41) :31792-31797
[5]   INSULIN ACTION AND THE INSULIN SIGNALING NETWORK [J].
CHEATHAM, B ;
KAHN, CR .
ENDOCRINE REVIEWS, 1995, 16 (02) :117-142
[6]   Insulin resistance differentially affects the PI3-kinase- and MAP kinase-mediated signaling in human muscle [J].
Cusi, K ;
Maezono, K ;
Osman, A ;
Pendergrass, M ;
Patti, ME ;
Pratipanawatr, T ;
DeFronzo, RA ;
Kahn, CR ;
Mandarino, LJ .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (03) :311-320
[7]   Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[8]   The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm [J].
Dandona, P ;
Aljada, A ;
Mohanty, P .
DIABETOLOGIA, 2002, 45 (06) :924-930
[9]   Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia [J].
Draznin, B ;
Miles, P ;
Kruszynska, Y ;
Olefsky, J ;
Friedman, J ;
Golovchenko, I ;
Stjernholm, R ;
Wall, K ;
Reitman, M ;
Accili, D ;
Cooksey, R ;
McClain, D ;
Goalstone, M .
ENDOCRINOLOGY, 2000, 141 (04) :1310-1316
[10]   Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site [J].
Du, XL ;
Edelstein, D ;
Dimmeler, S ;
Ju, QD ;
Sui, C ;
Brownlee, M .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (09) :1341-1348